Updates
** Shares of Torrent Pharma TORP.NS climb as much as 2.5% to a record high of 3,713.1 rupees
** Stock is second-top gainer in the pharma sub-index .NIPHARM, which is up 0.18%
** The drugmaker's Q1 consol net profit up 20% y/y on strong demand for drugs used to treat long-term conditions
** At least 10 brokerages increased PTs after the results, raising median PT to 3,800 rupees from 3,580 rupees last month, as per data compiled by LSEG
** HSBC says continued traction in TORP's India and Brazil segments, a pick-up in U.S. sales to support a healthy EBITDA margin outlook
** Co expects EBITDA margins of at least 32.9% for the remaining quarters of FY26; its operating EBITDA margins stood at 32.5% in Q1
** Jefferies expects TORP's India, Brazil sales to continue outperforming, while losses in U.S. likely to reduce through fiscal year
** TORP up ~8% YTD, as of Monday's close
(Reporting by Manvi Pant in Bengaluru)
((Manvi.Pant@thomsonreuters.com; +918447554364;))